Concurrent opioid and alcohol withdrawal management
Concurrent alcohol and opioid withdrawal syndrome is a common and challenging clinical scenario with little published evidence or guidance to inform pharmacotherapy strategies. Concurrent use of benzodiazepines and opioid agonists, which are considered first-line agents for management of each withdr...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association of Psychiatric Pharmacists
2023-12-01
|
Series: | Mental Health Clinician |
Subjects: | |
Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2023.12.268 |
_version_ | 1797404038260588544 |
---|---|
author | Michelle Colvard, PharmD, BCPP |
author_facet | Michelle Colvard, PharmD, BCPP |
author_sort | Michelle Colvard, PharmD, BCPP |
collection | DOAJ |
description | Concurrent alcohol and opioid withdrawal syndrome is a common and challenging clinical scenario with little published evidence or guidance to inform pharmacotherapy strategies. Concurrent use of benzodiazepines and opioid agonists, which are considered first-line agents for management of each withdrawal syndrome independently, is controversial and often avoided in clinical practice. Strategies to provide effective, simultaneous medication treatment of alcohol and opioid withdrawal while optimizing patient safety are demonstrated through 3 patient cases. |
first_indexed | 2024-03-09T02:48:09Z |
format | Article |
id | doaj.art-517a331feab94069a9e0ba64cb7030e9 |
institution | Directory Open Access Journal |
issn | 2168-9709 |
language | English |
last_indexed | 2024-03-09T02:48:09Z |
publishDate | 2023-12-01 |
publisher | American Association of Psychiatric Pharmacists |
record_format | Article |
series | Mental Health Clinician |
spelling | doaj.art-517a331feab94069a9e0ba64cb7030e92023-12-05T15:09:07ZengAmerican Association of Psychiatric PharmacistsMental Health Clinician2168-97092023-12-0113626827510.9740/mhc.2023.12.268i2168-9709-13-6-268Concurrent opioid and alcohol withdrawal managementMichelle Colvard, PharmD, BCPPConcurrent alcohol and opioid withdrawal syndrome is a common and challenging clinical scenario with little published evidence or guidance to inform pharmacotherapy strategies. Concurrent use of benzodiazepines and opioid agonists, which are considered first-line agents for management of each withdrawal syndrome independently, is controversial and often avoided in clinical practice. Strategies to provide effective, simultaneous medication treatment of alcohol and opioid withdrawal while optimizing patient safety are demonstrated through 3 patient cases.https://theijpt.org/doi/pdf/10.9740/mhc.2023.12.268alcohol withdrawalopioid withdrawalbenzodiazepinesmedications for opioid use disordermedications for alcohol use disorder |
spellingShingle | Michelle Colvard, PharmD, BCPP Concurrent opioid and alcohol withdrawal management Mental Health Clinician alcohol withdrawal opioid withdrawal benzodiazepines medications for opioid use disorder medications for alcohol use disorder |
title | Concurrent opioid and alcohol withdrawal management |
title_full | Concurrent opioid and alcohol withdrawal management |
title_fullStr | Concurrent opioid and alcohol withdrawal management |
title_full_unstemmed | Concurrent opioid and alcohol withdrawal management |
title_short | Concurrent opioid and alcohol withdrawal management |
title_sort | concurrent opioid and alcohol withdrawal management |
topic | alcohol withdrawal opioid withdrawal benzodiazepines medications for opioid use disorder medications for alcohol use disorder |
url | https://theijpt.org/doi/pdf/10.9740/mhc.2023.12.268 |
work_keys_str_mv | AT michellecolvardpharmdbcpp concurrentopioidandalcoholwithdrawalmanagement |